PMID: 6539201Apr 1, 1984Paper

Patient motivation and informed consent in a phase I study of an anticancer agent

European Journal of Cancer & Clinical Oncology
S RodenhuisN H Mulder

Abstract

In order to evaluate the quality of an informed consent procedure (I.C.P.) 48 patients with advanced cancer were offered participation in a phase I clinical trial and entered an I.C.P. consisting of three separate conversations. In the first session, the possible risks and benefits of a phase I study were informally explained by the patient's personal physician. The second session was attended by the patient, a relative, a registered nurse and a physician; the third session was held at least 5 days after the second. Forty-one patients gave their consent motivated by hope for improvement of their conditions, pressure exerted by relatives and friends, the desire to contribute to the progress of medicine or simply because they felt they had 'no choice'. Encouragement by relatives or friends seems to be a powerful incentive to participate. A period of a few days to consult relatives, friends or trusted physicians as a part of the procedure seems helpful in arriving at a well-considered decision.

References

Jul 1, 1977·Cancer·S K Carter
May 1, 1979·American Journal of Ophthalmology·I A PriluckH Buettner
Apr 1, 1979·Cancer·H B MussC L Spurr
Feb 23, 1978·The New England Journal of Medicine·J M Vaccarino
Apr 12, 1976·JAMA : the Journal of the American Medical Association·E G Laforet
Jan 1, 1983·Cancer Chemotherapy and Pharmacology·S RodenhuisJ C van de Grampel
Sep 1, 1981·The American Journal of Medicine·F M Muggia

❮ Previous
Next ❯

Citations

Dec 21, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Elizabeth L StrevelLillian L Siu
Apr 7, 1996·Health Policy·F W Verheggen, F C van Wijmen
Jan 7, 1999·Social Science & Medicine·S J EdwardsJ Hewison
Mar 8, 2000·Patient Education and Counseling·L Sherliker, A Steptoe
Apr 12, 2001·Journal of Advanced Nursing·S Moore
Feb 8, 2003·Journal of Palliative Medicine·Manish Agrawal, Marion Danis
Jun 3, 1998·Journal of the American Medical Informatics Association : JAMIA·H B JimisonY LeVernois
Feb 23, 2010·Medizinische Klinik·Charly GaulJohannes Haerting
Dec 15, 2010·Contemporary Clinical Trials·Leanne Stunkel, Christine Grady
Sep 1, 2009·American Journal of Surgery·Matthew E FalagasGeorge Peppas
Jun 6, 2003·European Journal of Cancer Care·K Cox, J McGarry
Aug 3, 2006·Behavioral Sciences & the Law·Laura B Dunn
Apr 29, 1998·Journal of the American Geriatrics Society·J SugarmanR C Hubal
Apr 18, 2015·Bulletin of the World Health Organization·Nguyen Thanh TamJuntra Karbwang
Sep 1, 2015·Clinical Trials : Journal of the Society for Clinical Trials·Louisa WallRebecca D Pentz
Aug 5, 2011·Clinical Trials : Journal of the Society for Clinical Trials·Tony H TruongSteven Joffe
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Manish AgrawalEzekiel J Emanuel
Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rebecca D PentzJames L Abbruzzese
Jan 1, 1989·Acta Oncologica·Y Willems, C Sessa
Jul 19, 2005·Accountability in Research·Neal DickertHolly Taylor
Apr 24, 2009·Journal of Empirical Research on Human Research Ethics : JERHRE·Nancy KassHerbert Hurwitz
Sep 19, 2002·Cancer·David J CasarettKaren B Hirschman
Jul 10, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fay J HlubockyChristopher K Daugherty
Jun 10, 2003·Arthritis and Rheumatism·Lisa G CriscioneE William St Clair
Aug 29, 2001·International Anesthesiology Clinics·M Miller
Jan 10, 2019·Pediatric Blood & Cancer·Bryan A SiskLiza-Marie Johnson
Apr 28, 2006·Current Opinion in Psychiatry·Laura B Dunn, Laura Weiss Roberts
Jan 1, 1993·Journal of General Internal Medicine·R M Arnold, L Forrow
Jun 6, 2000·Archives of General Psychiatry·L W Roberts
Aug 15, 2018·Neurology. Clinical Practice·Shelly BenjaminyAnthony Traboulsee
Aug 25, 2017·Journal of Oncology Practice·Katherine E Reeder-HayesElizabeth C Dees
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C K Daugherty
Jan 19, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J D ChengN J Meropol

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.